BSE filing, NSE: NIVABUPA. Summary written from the filing by ALFA Finder's alert engine.
Niva Bupa Health Insurance Company Ltd: key numbers
- Share price
- ₹72.86
- Market cap
- ₹13,477 Cr
- Revenue (annual)
- ₹6,695 Cr
- Net profit (annual)
- ₹130.8 Cr
- P/E (TTM)
- 37.4×Sector 19.7×
- Promoter holding
- 55.29%-0.01% QoQ
- FII holding
- 12.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niva Bupa Health Insurance Company Ltd
All →Niva Bupa Health Insurance Company Management Change
Niva Bupa Health Insurance Company Limited announced the sad demise of Mr. Roger William John Davis, a Non-Executive Non-Independent Director, effective October 17, 2026.
Niva Bupa Health Insurance Company Other Announcement
Niva Bupa Health Insurance announced the sad demise of Non-Executive Director Mr. Roger William John Davis, effective October 17, 2026.
Niva Bupa Health Insurance Company Credit Rating
Niva Bupa Health Insurance received a credit rating of IND AAA/Stable for its proposed subordinated debt issuance. This rating reflects the company's proposed debt instrument.
Niva Bupa Health Insurance Company Debt & Borrowing: ₹150 Cr
Niva Bupa Health Insurance will exercise its call option to redeem 1,500 non-convertible debentures on November 15, 2026, for a total principal amount of ₹150 Crore.
- Value
- ₹150.0 Cr
Niva Bupa Health Insurance Company Board Meeting Date
Niva Bupa Health Insurance will hold a committee meeting on 09-Oct-2026 to consider altering the payment date for interest or redemption amounts on debt securities.
Niva Bupa Health Insurance Company Debt & Borrowing: ₹150 Cr
Niva Bupa Health Insurance will hold a Debt Raising Committee meeting on October 9, 2026, to approve the redemption of NCDs aggregating to ₹150 Crore.
- Value
- ₹150.0 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.